Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
4,97 USD | -5,15% | +16,12% | +17,77% |
17/04 | Deals van de dag - Fusies en overnames | RE |
17/04 | Vanda Pharmaceuticals verwerpt overnamevoorstel van Future Pak | RE |
Omzet 2022 | 254 mln. 239 mln. | Omzet 2023 | 193 mln. 181 mln. | Marktkapitalisatie | 243 mln. 228 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | 6 mln. 5,63 mln. | Nettowinst (verlies) 2023 | 2 mln. 1,88 mln. | EV/omzet 2022 | -0,15 x |
Nettoliquiditeiten 2022 | 456 mln. 427 mln. | Nettoliquiditeiten 2023 | 379 mln. 355 mln. | EV/omzet 2023 | -0,71 x |
K/w-verhouding 2022 |
67,2
x | K/w-verhouding 2023 |
106
x | Werknemers | 203 |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 94,79% |
Recentste transcriptie over Vanda Pharmaceuticals Inc.
1 dag | -5,15% | ||
1 week | +16,12% | ||
Lopende maand | +20,92% | ||
1 maand | +32,53% | ||
3 maanden | +34,69% | ||
6 maanden | +10,94% | ||
Lopend jaar | +17,77% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 64 | 01-11-02 | |
Kevin Moran
DFI | Director of Finance/CFO | 40 | 01-12-12 |
Scott Howell
HRO | Human Resources Officer | - | 01-08-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Richard W. Dugan
BRD | Director/Board Member | 82 | 01-12-05 |
Chief Executive Officer | 64 | 01-11-02 | |
Director/Board Member | 72 | 14-02-20 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.34% | 29 M€ | -6,85% | ||
0.22% | 27 M€ | -7,00% | - | |
0.05% | 0 M€ | 0,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
18-04-24 | 4,97 | -5,15% | 3 859 528 |
17-04-24 | 5,24 | +29,38% | 24 035 651 |
16-04-24 | 4,05 | -0,25% | 790 418 |
15-04-24 | 4,06 | -1,46% | 787 157 |
12-04-24 | 4,12 | -3,74% | 762 864 |
uitgestelde koers Nasdaq, 18 april 2024 om 22:00 uur
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
+17,77% | 286 mln. | |
-3,30% | 102 mld. | |
+1,79% | 96,07 mld. | |
-0,93% | 21,66 mld. | |
-18,35% | 20,77 mld. | |
-7,70% | 18,53 mld. | |
-40,31% | 16,91 mld. | |
-26,84% | 13,79 mld. | |
+0,59% | 13,33 mld. | |
+20,86% | 10,94 mld. |